Geneva, May 20 -- International Clinical Trials Registry received information related to the study (ACTRN12625000408482) titled 'Optimal heart rates in patients with Cardiac Amyloidosis and pacemakers.' on May 5.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Primary Sponsor: St Vincent's Hospital Sydney
Condition:
Amyloidosis
Amyloidosis
Cardiovascular - Other cardiovascular diseases
Human Genetics and Inherited Disorders - Other human genetics and inherited disorders
Intervention:
Prospective pilot study of cardiac pacing augmented myocardial dynamics in patients with transthyretin cardiac amyloidosis. The study includes enrolment then two site study ...